Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline Resectable Pancreatic Ductal Adenocarcinoma”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableLooking for participantsNCT06320717
What this trial is testing

AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute 100
Not applicableLooking for participantsNCT06595160
What this trial is testing

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8
Emory University 87
Not applicableUnknownNCT05489458
What this trial is testing

Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy

Who this might be right for
Carcinoma, Pancreatic Ductal
BUSQUETS, JULI 100
Not applicableStudy completedNCT05888129
What this trial is testing

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Postoperative Complications
Asan Medical Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06821997
What this trial is testing

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)UnknownNCT01676259
What this trial is testing

SiG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Silenseed Ltd 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04481204
What this trial is testing

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center 105
Testing effectiveness (Phase 2)Study completedNCT02723331
What this trial is testing

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaPancreas Ductal Adenocarcinoma
Academic Thoracic Oncology Medical Investigators Consortium 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573398
What this trial is testing

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

Who this might be right for
Carcinoma, Pancreatic Ductal
Ruijin Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Not applicableUnknownNCT04915417
What this trial is testing

Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma

Who this might be right for
Resectable Pancreatic AdenocarcinomaBorderline Resectable Pancreatic Adenocarcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 30
Early research (Phase 1)Looking for participantsNCT04484909
What this trial is testing

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma+1 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT06141031
What this trial is testing

Phase I/IB Trial of Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
University of Colorado, Denver 18
Early research (Phase 1)Active Not RecruitingNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Not applicableUnknownNCT04855331
What this trial is testing

Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC

Who this might be right for
Borderline Resectable Pancreatic Cancer
Fudan University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05562297
What this trial is testing

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Stage IBPancreatic Cancer, Stage IIAPancreatic Cancer, Stage IIB+1 more
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07269626
What this trial is testing

PULSAR in Systemic Therapy for Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaOligometastatic Pancreatic Ductal Adenocarcinoma
Samsung Medical Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT05851924
What this trial is testing

NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Ended earlyNCT01431794
What this trial is testing

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Very early researchStudy completedNCT03970252
What this trial is testing

Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma
Jonsson Comprehensive Cancer Center 28
Load More Results